Purpose A cohort study was carried out to test the hypothesis that higher vitamin D levels
reduce the risk of relapse from melanoma. Methods A pilot retrospective study of 271 patients …

High-resolution ocean velocity data has become readily available since the introduction of
very high frequency (VHF) radar technology. The vast amount of data generated so far, …

Background Many randomised trials assessing interferon-α (IFN-α) as adjuvant therapy for
high-risk malignant melanoma have been undertaken. To better assess the role of IFN-α, an …

We have carried out melanoma case–control comparisons for six vitamin D receptor (VDR)
gene single nucleotide polymorphisms (SNPs) and serum 25-hydroxyvitamin D 3 levels in …

Background Surgery is the only curative treatment for primary cutaneous melanoma, therefore
it is important to determine excision margins that minimise risk of local recurrence, distant …

Background Bevacizumab is a recombinant humanised monoclonal antibody to vascular
endothelial growth factor shown to improve survival in advanced solid cancers. We evaluated …

We report an investigation of gene dosage at 9p21.3 and mutations in BRAF and NRAS, as
predictors of relapse and histological markers of poor melanoma prognosis. Formalin‐fixed …

Background Topical imiquimod is sometimes used for lentigo maligna (LM) in situ melanoma
instead of surgery, but frequency of cure is uncertain. Pathological complete regression (…

Melanoma of the skin is an increasingly common tumour, which often has a slow early growth
rate during which curable lesions may be detected and removed. Physicians therefore …

The ABC of Skin Cancer is designed to boost GP confidence in the diagnosis and referral of
skin cancer, focusing on differential diagnosis and common pitfalls. In line with the latest …